Investor Relations

CHF Solutions is an early stage company focused on commercializing the Aquadex FlexFlow® system. Our objective is to improve the quality of life for patients with heart failure and related conditions, such as fluid overload. CHF Solutions is listed on the NASDAQ Capital Market.

Press Releases

Posted on Jun 29, 2017
EDEN PRAIRIE, Minn., June 29, 2017 (GLOBE NEWSWIRE) -- CHF Solutions, Inc., (fka Sunshine Heart, Inc.) (NASDAQ:CHFS) announced today that researchers in the Stanford University School of Medicine's Department of Pediatrics have received FDA Investigational Device Exemption (IDE) approval to conduc...

Read More

Posted on Jun 6, 2017
EDEN PRAIRIE, Minn., June 06, 2017 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (NASDAQ:CHFS), today announced that on May 25, 2017, the independent directors approved two equity awards under CHF Solution's New-Hire Equity Incentive Plan, as material inducements to two individuals entering into employm...

Read More

Posted on Jun 5, 2017
EDEN PRAIRIE, Minn., June 05, 2017 (GLOBE NEWSWIRE) -- CHF Solutions, Inc., (fka Sunshine Heart, Inc.) (NASDAQ:CHFS) announced today that clinical trials using its Aquadex FlexFlow® Ultrafiltration System are featured in the May 2017 Journal of the American College of Cardiology (JACC) Treatm...

Read More

Events & Presentations

Posted on May 9, 2017 at 9:00 AM ET
Posted on Mar 2, 2017 at 9:00 AM ET
Posted on Nov 8, 2016 at 9:00 AM ET